tetano
Editor, Senior Moderator
Hum Vaccin Immunother. 2015 Dec 2;11(12):2849-51. doi: 10.1080/21645515.2015.1075108.
[h=1]Current status and uptake of influenza vaccination over time among senior adults in the United States.[/h] Lu PJ[SUP]1[/SUP], O'Halloran A[SUP]1[/SUP], Ding H[SUP]1[/SUP], Greby SM[SUP]1[/SUP], Williams WW[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Influenza is a major cause of morbidity and mortality among older adults in the United States, who may also have chronic medical conditions that place them at high risk for complications from influenza. The U.S. Public Health Service recommended influenza vaccination of adults ≥65 y and chronically ill persons since 1961 and beginning with the 2010-11 influenza season, the Advisory Committee on Immunization Practices (ACIP) has expanded its recommendation to vaccinate all persons 6 months of age and older. Medicare coverage for influenza vaccination began in 1993. However, despite the presence of a safe and effective vaccine, long-standing recommendations on vaccination, and federal financial support for vaccination, vaccination levels among adults ≥65 y are not optimal. Studies have shown that influenza vaccination coverage among U.S. adults ≥ 65 y steadily increased from 30.1% in 1989 to 64.2% in 1997, but plateaued near 65% from 1998 to 2013. Increasing influenza vaccination coverage among older adults in the United States will require more cooperation among health-care providers, professional organizations, vaccine manufacturers, and public health departments to raise public awareness about the benefits of influenza vaccination and to ensure continued administration of vaccinations throughout the influenza season.
[h=4]KEYWORDS:[/h] influenza; influenza vaccination; senior adults; vaccination coverage
PMID: 26697974 [PubMed - in process]
[h=1]Current status and uptake of influenza vaccination over time among senior adults in the United States.[/h] Lu PJ[SUP]1[/SUP], O'Halloran A[SUP]1[/SUP], Ding H[SUP]1[/SUP], Greby SM[SUP]1[/SUP], Williams WW[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Influenza is a major cause of morbidity and mortality among older adults in the United States, who may also have chronic medical conditions that place them at high risk for complications from influenza. The U.S. Public Health Service recommended influenza vaccination of adults ≥65 y and chronically ill persons since 1961 and beginning with the 2010-11 influenza season, the Advisory Committee on Immunization Practices (ACIP) has expanded its recommendation to vaccinate all persons 6 months of age and older. Medicare coverage for influenza vaccination began in 1993. However, despite the presence of a safe and effective vaccine, long-standing recommendations on vaccination, and federal financial support for vaccination, vaccination levels among adults ≥65 y are not optimal. Studies have shown that influenza vaccination coverage among U.S. adults ≥ 65 y steadily increased from 30.1% in 1989 to 64.2% in 1997, but plateaued near 65% from 1998 to 2013. Increasing influenza vaccination coverage among older adults in the United States will require more cooperation among health-care providers, professional organizations, vaccine manufacturers, and public health departments to raise public awareness about the benefits of influenza vaccination and to ensure continued administration of vaccinations throughout the influenza season.
[h=4]KEYWORDS:[/h] influenza; influenza vaccination; senior adults; vaccination coverage
PMID: 26697974 [PubMed - in process]